§ Funding Round
Series C funding round for Inversago Pharma raising $69M in October 2022
Series C funding round for Inversago Pharma raising $69M in October 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Advent Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Bond | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | ed mathers | |
New Enterprise AssociatesLEAD | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
JDRF | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$111M
Top Valuation
-
Inversago Pharma raised $69M in a Series C round.
The round was announced on 10/01/22.
The round was led by New Enterprise Associates.
